Keyuan Pharma Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Public

  • Employees
  • 650

Employees

  • Stock Symbol
  • 301281

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $4.25
  • (As of Friday Closing)

Keyuan Pharma General Information

Description

Shandong Keyuan Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of chemical raw materials and their preparations.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Keyuan Street, Shandong Shanghe Economic Development Zone
  • Jinan, Shandong
  • China
+86 0531
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
SHE
Corporate Office
  • Keyuan Street, Shandong Shanghe Economic Development Zone
  • Jinan, Shandong
  • China
+86 0531

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Keyuan Pharma Stock Performance

As of 20-Nov-2026, Keyuan Pharma’s stock price is $4.25. Its current market cap is $460M with 108M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.25 $4.61 $3.67 - $8.72 $460M 108M 2.28M $0.09

Keyuan Pharma Financials Summary

As of 30-Sep-2026, Keyuan Pharma has a trailing 12-month revenue of $83.9M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 757,539 420,817 381,615 428,325
Revenue 83,868 55,376 64,625 63,264
EBITDA 11,959 9,411 15,239 17,656
Net Income 10,217 2,302 8,424 10,889
Total Assets 293,660 241,209 212,665 207,371
Total Debt 32,601 16,057 6,255 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Keyuan Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Keyuan Pharma‘s full profile, request access.

Request a free trial

Keyuan Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Keyuan Pharma Investments (2)

Keyuan Pharma’s most recent deal was a Later Stage VC with Drug Farm for . The deal was made on 13-Jul-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Drug Farm 13-Jul-2026 Later Stage VC Drug Discovery
Beijing Nuokangda Pharmaceutical Technology 11-Nov-2023 Secondary Transaction - Private Drug Discovery
To view Keyuan Pharma’s complete investments history, request access »

Keyuan Pharma ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Chemicals

Industry

Rank

Percentile

Commodity Chemicals

Subindustry

Rank

Percentile

To view Keyuan Pharma’s complete esg history, request access »

Keyuan Pharma FAQs

  • When was Keyuan Pharma founded?

    Keyuan Pharma was founded in 2004.

  • Where is Keyuan Pharma headquartered?

    Keyuan Pharma is headquartered in Jinan, China.

  • What is the size of Keyuan Pharma?

    Keyuan Pharma has 650 total employees.

  • What industry is Keyuan Pharma in?

    Keyuan Pharma’s primary industry is Drug Discovery.

  • Is Keyuan Pharma a private or public company?

    Keyuan Pharma is a Public company.

  • What is Keyuan Pharma’s stock symbol?

    The ticker symbol for Keyuan Pharma is 301281.

  • What is the current stock price of Keyuan Pharma?

    As of 20-Nov-2026 the stock price of Keyuan Pharma is $4.25.

  • What is the current market cap of Keyuan Pharma?

    The current market capitalization of Keyuan Pharma is $460M.

  • What is Keyuan Pharma’s current revenue?

    The trailing twelve month revenue for Keyuan Pharma is $83.9M.

  • What is Keyuan Pharma’s annual earnings per share (EPS)?

    Keyuan Pharma’s EPS for 12 months was $0.09.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process